Cytomegalovirus viral load and antigenemia in the monitorization of prophylactic treatment with valganciclovir in renal transplant recipients;Carga viral y antigenemia de citomegalovirus en la monitorización de la profilaxis con valganciclovir en pacientes con trasplante renal

Revista Espanola de Quimioterapia

Volumn 18, Issue 3, 2005, Pages 226-229

  Bordils, A ^a   Molina, J M ^a   Cordoba J ^a   Ramos, D ^a   Beneyto, I ^a   Mascaros V ^a   Sanchez Plumed J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cytomegalovirus; Renal transplant; Valganciclovir; Viral load

Indexed keywords

ARTICLE; BIOLOGICAL MONITORING; CHEMOPROPHYLAXIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; DRUG EFFICACY; FOLLOW UP; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MEASUREMENT; POLYMERASE CHAIN REACTION; RECIPIENT; URINALYSIS; VIRUS LOAD;

ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG MONITORING; GANCICLOVIR; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 28844475455     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fishman, J.A., Rubin, R.H. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.
2. Rubin, R.H. Cytomegalovirus in solid organ transplantation. Transplant Infect Dis 2001; 3: 1-5.
3. Schöeder, R., Michelon, T., Fagundes, I. y cols. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. Transplant Proc 2004; 36: 896-898.
4. Ljungman, P., Griffiths, P., Paya, C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
5. Opelz, G., Döhler, B., Ruhenstroth, A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 928-936.
6. Borchers, A.T., Pérez, R., Kaysen, G., Ansari, A., Gershwin, M.E. Role of cytomegalovirus infection in allograft rejection: A review of possible mechanisms. Transplant Immunol 1999; 7: 75-82.
7. Sagedal, S., Nordal, K.P., Hartman, A. y cols. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002; 850-856.
8. Danovich, G.M. Handbook of kidney transplantation. Infections in kidney transplantation. Lippincott Williams & Wilkins, Baltimore 2005; 286-287.
9. Humar, A., Paya, C., Pescovitz, M.D. y cols. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R-solid organ transplant recipients. Am J Transplant 2004; 4: 644-649.
10. Razonable, R.R., Paya, C.V. Valganciclovir for prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther 2004; 2: 27-41.
11. Babel, N., Gabdrakhmanov, L., Juergensen, J.S. y cols. Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: A single center experience. Transplantation 2004; 78: 283-285.
12. Casillo, R., Grimaldi, M., Ragone, E. y cols. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients. Transplant Proc 2004; 36: 651-653.
13. Razonable, R.R., Brown, R.A., Wilson, J. y cols. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantification in transplant recipients with CMV disease. Transplantation 2002; 73: 968-973.
14. Kalpoe, J.S., Kroes, A.C., de Jong, M.D. y cols. Validation of clinical application of cytomegalovirus plasma DNA load measurements and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004; 424: 1498-1504.
15. Pancholi, P., Wu, F., Della-Latta, P. Rapid detection of cytomegalovirus infection in transplant patients. Expert Rev Mol Diagn 2004; 4: 231-242.
16. Sia, I.G., Wilson, J.A., Groettum, C.M. y cols. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000; 181: 717-720.
17. Boeckh, M., Huang, M., Ferrenberg, J. y cols. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 2004; 42: 1142-1148.
18. Schöeder, R., Michelon, T., Fagundes, I. y cols. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation. Transplant Proc 2004; 36: 891-893.
19. Meyer-Koenig, U., Weidmann, M., Kirste, G., Hufter, F.T. Cytomegalovirus infection in organ-transplant recipients: Diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and quantitative Taqman PCR. Transplantation 2004; 77: 1692-1698.
20. Piiparinen, H., Hockerstedt, K., Gronhagen-Riska, C., Lautenschlager, I. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004; 30: 258-266.
21. Mengelle, C., Pasquier, C., Rostaing, L. y cols. Quantification of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Clin Microbiol 2003; 41: 3840-3845.
22. Gouarin, S., Vabret, A., Gault, E. y cols. Quantification analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. 3 Clin Virol 2004; 29: 194-201.
23. Xiao, Y., Shi, K., Mao, X. Detection of cytomegalovirus antigens and virus DNA in the peripheral blood after organ transplantation. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1999; 13: 287-290.
24. Li, H., Dummer, J.S., Estes, W.R. y cols. Measurements of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003; 41: 187-191.
25. Kouzarides, T., Bankier, A.T., Satchwell, S.C. y cols. Sequence and transcripcion analysis of the human cytomegalovirus DNA polymerase gene. J Virol 1987; 61: 125-133.
26. Sambrook, J., Fristh, E.F., Manniatis, T. Molecular cloning: A laboratory manual, 2nd. ed. Cold Spring Harbor Laboratory, NY 1989.
27. Longo, M.C., Berninger, M.S., Hartley, J.S. Use of uracil DNA glycosilase to control carry-over contamination in polymerase chain reaction. Gene 1990; 93: 125-128.